| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |